Starpharma with Proactive at the ASX Small and Mid-Cap Conference | News Direct

Starpharma with Proactive at the ASX Small and Mid-Cap Conference

Starpharma Holdings Limited
News release by Starpharma Holdings Limited

facebook icon linkedin icon twitter icon pinterest icon email icon Melbourne, Victoria | March 22, 2023 01:40 PM Eastern Daylight Time

Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) CEO Dr Jackie Fairley speaks with Proactive from the ASX Small and Mid-Cap Conference March 2023. The company is focused on the development of pharmaceutical and medical products for unmet patient needs, including in the areas of oncology and infectious diseases.

 

 

Contact Details

 

Proactive Investors

 

Jonathan Jackson

 

+61 413 713 744

 

jonathan@proactiveinvestors.com

project media

Tags

Starpharma Holdings LimitedbiotechAsxproactiveAustraliaproactiveInvestors